Sept 8 (Reuters) - The COVAX vaccine-sharing facility will
likely receive 1.425 billion doses of anti-COVID-19 shots from
donor countries this year, down from a July estimate of 2
billion, the GAVI Vaccine Alliance said on Wednesday.
Reasons for the cut include export restrictions on key
supplier Serum Institute of India (SII), Gavi said in a joint
statement with the Coalition for Epidemic Preparedness
Innovations (CEPI), the World Health Organization and Unicef.
Manufacturing problems at Johnson & Johnson and
AstraZeneca as well as delays in the regulatory review
of shots developed by U.S. biotech firm Novavax and
China's Clover Biopharmaceuticals were further limiting factors,
the organisations said.
(Reporting by Ludwig Burger and Alistair Smout; editing by
Jason Neely)